Business Context and Reporting Period
Company: AEye, Inc. (Ticker: LIDR)
Filing Type: Form 8-K (Current Report)
Date of Report: September 12, 2024
Event: Entry into a Material Definitive Agreement (At Market Issuance Sales Agreement).
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It details a new financing facility with the following parameters:
- Maximum Offering Size: Up to $2,600,000 in aggregate offering price.
- Sales Agent Commission: Up to 3.0% of gross proceeds paid to A.G.P./Alliance Global Partners.
- Financial Advisor Fee: Up to 1.0% of gross proceeds paid to WestPark Capital, Inc.
- Expense Reimbursement: Up to $50,000 for execution/implementation and up to $15,000 per fiscal year for periodic due diligence.
Material Changes
The primary material change is the establishment of an "at-the-market" (ATM) equity offering facility. This agreement allows the Company to sell common stock through A.G.P. acting as sales agent. The Company retains control over sale parameters, including timing, volume, and minimum price thresholds.
Guidance, Outlook, and Management Commentary
Use of Proceeds: The Company intends to use proceeds for working capital and general corporate purposes. Specific strategic goals include:
- Supporting future growth.
- Enhancing go-to-market strategies for the Apollo product.
- Increasing market penetration in the Chinese lidar sector.
Term and Termination: The offering facility will terminate upon the earliest of: (i) the 36-month anniversary of the prospectus supplement filing, (ii) the sale of all Placement Shares, or (iii) termination of the agreement by either party with 30 days' prior notice.
Investor Verification Checklist
- Verify the current share price and trading volume to assess the potential dilution impact of the $2.6 million ATM facility.
- Review the Company's most recent 10-Q or 10-K to determine current cash reserves and burn rate relative to the new funding capacity.
- Monitor future 8-K filings for actual sales executed under this agreement and the resulting dilution.
- Confirm the status of the Apollo product launch and specific milestones in the Chinese market to validate the stated use of proceeds.